Overview
ENTX market data
Price History
ENTX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.25 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.38 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -4,525.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.91 – $4.20 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $142.9M · P/B 6.79 · P/S 640.99.
Company News
Entera Bio Q2 EPS $(0.14) Misses $(0.08) EstimateBenzinga · Aug 7, 2026, 8:26 PM
Entera Bio Intends To File Ind For EB612 In First Half Of 2027; EB613 Phase 3 Study Initiation Planned For Late 2026, Topline Data Anticipated In Second Half 2028Benzinga · Aug 7, 2026, 8:24 PM
8-K filing — Entera Bio Ltd. (ENTX)SEC EDGAR · Aug 7, 2026, 8:06 PM
Entera Bio Announces That Post-Hoc Data From Its Phase 2 Clinical Trial Of EB613Has Been Selected For Two Presentations At The American Society For Bone And Mineral Research Annual MeetingBenzinga · Aug 4, 2026, 12:32 PM
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth ConferenceGlobenewswire Inc · Jul 31, 2026, 9:31 PM
Entera Bio Rebounds As Investors Balance Phase 3 Funding Against Dilution RiskBenzinga · Jul 29, 2026, 4:02 PM
Entera Bio shares are trading higher after the company announced pricing of oversubscribed $275 million private placement.Benzinga · Jul 27, 2026, 6:27 PM
Crude Oil Falls Sharply; US Durable Goods Orders Increase 0.3% In JuneBenzinga · Jul 27, 2026, 4:22 PM
Dow Jumps Over 400 Points; AstraZeneca Shares Rise After Q2 EarningsBenzinga · Jul 27, 2026, 2:21 PM
Entera Bio Enters Into Securities Purchase Agreement For Oversubscribed Private Placement Financing, Expected To Result In Aggregate Gross Proceeds Of ~$275MBenzinga · Jul 27, 2026, 12:33 PM